Novartis Diovan Manufacturing Plant,

Specifications - Novartis Diovan Manufacturing Plant, Schweizerhalle, Switzerland


Key Data
Order year1996
Plant typeNew plant
LocationSchweizerhalle, Switzerland
Estimated investment$103m (CHF170m), 2004 expansion CHF60m, 2006 expansion CHF75m, 2007 expansion CHF300m
Completion1999, 2004, 2008
Key Players
SponsorNovartis
FinancingNovartis
Output Chemicals
Vials per year36 million, increase in Diovan of 60t
Ampoules160 million
Featured Suppliers
CEPHA s.r.o. - Bioavailability and Bioequivalence Studies and Bioanalytical Services
MAVAG - FUNDAŽ-Filter Systems for Pharmaceutical Applications


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?